Lv12
90 积分 2021-07-12 加入
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial
1天前
待确认
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
1个月前
已完结
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
1个月前
已完结
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy in advanced squamous non-small-cell lung cancer (HARMONi-6): interim overall survival analysis of a randomised, double-blind, phase 3 trial in China
2个月前
已完结
Advancing AI for multi-omics and clinical data integration in basic and translational cancer research
2个月前
已完结
Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy
4个月前
已完结
Advances in the management of metastatic gastric cancer: current strategies and emerging therapeutics
4个月前
已完结
Claudin 18.2 as a novel therapeutic target
5个月前
已完结
Emerging targets in gastric and pancreatic cancer: Focus on claudin 18.2
5个月前
已完结
CCR8: a promising therapeutic target against tumor-infiltrating regulatory T cells
5个月前
已完结
皖公网安备34019202002308
